EU clinical trial portal and database declared functional | RAPS
Clinical Trial Regulation Update - PharSafer® - Specialists in Global Clinical and Post Marketing Drug Safety
EMA: Points to consider on implications of COVID-19 on methodological aspects of ongoing clinical trials - Meditrial Helpline
EMA Webinar for SMEs and Academia on the Clinical Trials Regulation and the Clinical Trials Information System | ERICA
Patient involvement in EMA regulatory committees - EUPATI Toolbox
Assessment of the Regulatory Dialogue Between Pharmaceutical Companies and the European Medicines Agency on the Choice of Noninferiority Margins - Clinical Therapeutics
Clément Provansal on LinkedIn: Regulatory harmonisation of clinical trials in the EU: Clinical Trials
Characteristics of Single Pivotal Trials Supporting Regulatory Approvals of Novel Non-orphan, Non-oncology Drugs in the European Union and United States from 2012-2016. - Abstract - Europe PMC
The European Medicines Agency and the Regulation of Medicines in the European Union - ScienceDirect
Clinical data publication | European Medicines Agency
Correspondence with the European Medicines Agency | The BMJ
EMA's Press Briefing on Clinical Trials Regulation, 25 January 2022 / Twitter
Change management for the EudraVigilance system | European Medicines Agency
Approval rating: how do the EMA and FDA compare? | Cancer World Archive
Approval rating: how do the EMA and FDA compare? | Cancer World Archive
Paediatric Clinical Trial Preparedness-EFGCP Webinar | ECRIN
Transparency of clinical trials and good governance should be included in the EMA extended mandate | European Alliance for Responsible R&D and Affordable Medicines
EMA Explains Dos And Don'ts Of New Clinical Trials Portal :: Pink Sheet
The obligatory sharing of clinical trial data in the European Union - datenschutz notizen | News-Blog der datenschutz nord Gruppe
EMA calls for 'stakeholder' input on design of new clinical trials database
The European Medicines Agency Clinical Data Website Enables Insights I | OAJCT
Clinical trials for EMA-submitted medicines move away from US and Europe - PMLiVE
Positive outcome for ema's policy 0070, one year after the publication of the clinical trial results - Portolano Cavallo
COVID-19 vaccines: development, evaluation, approval and monitoring | European Medicines Agency
